FDA Drug Application (011665) for MESTINON by VALEANT PHARMS LLC

Back to FDA Applications sponsored by VALEANT PHARMS LLC

Application Number011665
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage180MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMESTINON
Active IngredientPYRIDOSTIGMINE BROMIDE



Back to FDA Applications sponsored by VALEANT PHARMS LLC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.